# Phase 4 shock trials recruiting: 29 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials in phase 4 for shock that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 shock trials: 29 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/shock

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 29
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 11, 2026 | NCT07756801 | Capital Offload-Shock | Ottawa Heart Institute Research Corporation | Phase 4 | Not yet recruiting | Hypervolemia, Cardiogenic Shock, Renal Replacement Therapies | 456 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07756801) |
| April 14, 2026 | NCT07527156 | Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure | Institute for Clinical and Experimental Medicine | Phase 4 | Recruiting | Acute Heart Failure (AHF), Cardiogenic Shock, Heart Failure, Ketones, Ketone Body Metabolism | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07527156) |
| March 13, 2026 | NCT07470775 | Early Dexmedetomidine and Sympathetic Regulation in Sepsis | Sichuan Academy of Medical Sciences | Phase 4 | Not yet recruiting | Sepsis, Septic Shock | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470775) |
| February 3, 2026 | NCT07383103 | Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock | Northern Jiangsu People's Hospital | Phase 4 | Recruiting | Septic Shock | 336 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07383103) |
| January 7, 2026 | NCT07322133 | Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) | University of California, Davis | Phase 4 | Recruiting | Hypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory Failure | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322133) |
| June 25, 2025 | NCT07035509 | Randomized Control Study in REsuscitation of SEpsis Trial | Fundación Cardioinfantil Instituto de Cardiología | Phase 4 | Not yet recruiting | Septic Shock, Pediatric Critical Illness | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07035509) |
| April 18, 2025 | NCT06934811 | Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients | First Affiliated Hospital of Wannan Medical College | Phase 4 | Not yet recruiting | ECMO Treatment, ARDS (Acute Respiratory Distress Syndrome), ECMO and Acute MI, Respiratory Failure Patients Treated... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06934811) |
| April 18, 2025 | NCT06934798 | Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery | University of Sao Paulo | Phase 4 | Recruiting | Vasoplegic Syndrome of Cardiac Surgery | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06934798) |
| April 8, 2025 | NCT06915506 | Shenfu Injection Modulates Carotid Elasticity in Septic Shock | First Affiliated Hospital of Wannan Medical College | Phase 4 | Not yet recruiting | Septic Shock, Vascular Dysfunction, Arterial Stiffness, Carotid Artery Elasticity Alterations, Sepsis | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06915506) |
| March 27, 2025 | NCT06898723 | The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis | First Affiliated Hospital of Wannan Medical College | Phase 4 | Recruiting | Septic Cardiomyopathy, Septic Shock | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06898723) |
| March 18, 2025 | NCT06881927 | Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock... | University Hospital, Strasbourg, France | Phase 4 | Recruiting | Sepsis and Septic Shock, Acute Respiratory Failure, Kidney Transplant Recipients, Immunosuppressive Agents | 212 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06881927) |
| January 9, 2025 | NCT06766461 | Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis | Erasmus Medical Center | Phase 4 | Recruiting | Sepsis - to Reduce Mortality in the Intensive Care Unit, Sepsis, Septic Shock | 980 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06766461) |
| December 24, 2024 | NCT06746753 | Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock | Wake Forest University Health Sciences | Phase 4 | Not yet recruiting | Septic Shock | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06746753) |
| November 29, 2024 | NCT06709573 | Early Versus Late Adjunctive Vasopressin in Septic Shock | The Cleveland Clinic | Phase 4 | Recruiting | Sepsis, Septic Shock | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06709573) |
| November 20, 2024 | NCT06696235 | Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal... | Samsung Medical Center | Phase 4 | Recruiting | Cardiogenic Shock, Acute Kidney Injury | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06696235) |
| November 18, 2024 | NCT06693726 | Early Angiotensin II in the Emergency Department | Sponsor not shown (see the record) | Phase 4 | Recruiting | Septic Shock | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06693726) |
| November 1, 2024 | NCT06670963 | Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial | Sponsor not shown (see the record) | Phase 4 | Recruiting | Anemia, Sepsis, Septic Shock | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06670963) |
| June 4, 2024 | NCT06442267 | Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support | Medical University of Vienna | Phase 4 | Recruiting | Respiratory Insufficiency, Circulatory Failure, Thromboembolism, Bleeding | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06442267) |
| December 28, 2023 | NCT06184659 | Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis | Scandinavian Critical Care Trials Group | Phase 4 | Recruiting | Sepsis, Septic Shock | 5,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06184659) |
| July 21, 2023 | NCT05956418 | A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients | Pharmazz, Inc. | Phase 4 | Recruiting | Hypovolemic Shock | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05956418) |
| May 1, 2023 | NCT05836272 | Early Administration of Norepinephrine in Sepsis | Tunis University | Phase 4 | Recruiting | Sepsis, Severe | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05836272) |
| September 10, 2022 | NCT05534971 | Central Line Study | Montefiore Medical Center | Phase 4 | Recruiting | Shock | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05534971) |
| September 2, 2022 | NCT05527717 | Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing... | Samsung Medical Center | Phase 4 | Recruiting | Cardiogenic Shock, Acute Myocardial Infarction, Multi Vessel Coronary Artery Disease, Extracorporeal Membrane... | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05527717) |
| July 19, 2022 | NCT05463471 | Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients | Peking Union Medical College Hospital | Phase 4 | Not yet recruiting | Shock | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05463471) |
| March 4, 2022 | NCT05267886 | CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock | Ottawa Heart Institute Research Corporation | Phase 4 | Recruiting | Shock, Cardiogenic | 346 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05267886) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| First Affiliated Hospital of Wannan Medical College | 3 |
| Ottawa Heart Institute Research Corporation | 2 |
| Samsung Medical Center | 2 |
| University of California, Davis | 1 |
| University of Alberta | 1 |
| Institute for Clinical and Experimental Medicine | 1 |
| Medical University of Vienna | 1 |
| Sichuan Academy of Medical Sciences | 1 |
| The Cleveland Clinic | 1 |
| Erasmus Medical Center | 1 |
| Scandinavian Critical Care Trials Group | 1 |
| Tunis University | 1 |
| University Hospital, Strasbourg, France | 1 |
| Wake Forest University Health Sciences | 1 |
| University of Sao Paulo | 1 |
| Fundación Cardioinfantil Instituto de Cardiología | 1 |
| Montefiore Medical Center | 1 |
| Asan Medical Center | 1 |
| Peking Union Medical College Hospital | 1 |
| University of Chicago | 1 |
| Northern Jiangsu People's Hospital | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Pharmazz, Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| Canada | 3 |
| South Korea | 3 |
| China | 3 |
| Netherlands | 2 |
| Czechia | 1 |
| Austria | 1 |
| Denmark | 1 |
| Tunisia | 1 |
| France | 1 |
| Brazil | 1 |
| Colombia | 1 |
| Poland | 1 |
| India | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [B2B transportation and storage companies in the United States](https://specstream.ai/data/businesses/b2b-transportation-and-storage-companies/united-states)
- [West African restaurants in the United States](https://specstream.ai/data/businesses/west-african-restaurants/united-states)
- [Speech training companies in the United States](https://specstream.ai/data/businesses/speech-training-companies/united-states)
- [Pool cleaning companies in the United States](https://specstream.ai/data/businesses/pool-cleaning-companies/united-states)
- [Medical transportation companies in the United States](https://specstream.ai/data/businesses/medical-transportation-companies/united-states)
